Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of DW5421A/DW5421B Compared to Monotherapy of DW5421A

NCT07444762 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

184

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Hypercholesterolemia
Mixed Dyslipidemia

Interventions

DRUG: DW5421A
DRUG: DW5421B Placebo
DRUG: DW5421B

Sponsor

Daewon Pharmaceutical Co., Ltd.